Skip Navigation LinksHome > March 2014 - Volume 21 - Issue 3 > Individualizing osteoporosis medications
doi: 10.1097/GME.0000000000000180
Clinical Corner: Clinical Article

Individualizing osteoporosis medications

Silverman, Stuart MD, FACP, FACR

Collapse Box


Clinical Scenario: Mrs. JD is a 58-year-old postmenopausal woman having symptoms of hot flashes and night sweats. She has a dual-energy x-ray absorptiometry T-score of −2.4 in the femoral neck, consistent with low bone mass or osteopenia. She has a parental history of hip fracture. FRAX shows the 10-year absolute risk of major osteoporotic fracture equal to 18% and the 10-year risk of hip fracture above 3% at 3.2%, which meets the National Osteoporosis Foundation threshold. Mrs. JD is taking calcium 1,200 mg, between supplement and diet, and 1,000 IU vitamin D3 daily. How should she be treated?

© 2014 by The North American Menopause Society.


Article Tools


Article Level Metrics